Monkeypox vaccination program provider agreement

Details

• Corporate Authors:
  National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
• Description:
  Updated September 14, 2022
  
  The U.S. Department of Health and Human Services (HHS) and its components the Administration for Strategic Preparedness & Response (ASPR), Strategic National Stockpile (SNS), and the Centers for Disease Control and Prevention (CDC) greatly appreciate your organization’s participation in the HHS Monkeypox Vaccination Program.[1] With use of the JYNNEOS™ or ACAM2000® vaccine provided at no cost by the US government (this vaccine), the provider and provider’s organization (Organization) will be deemed to have agreed to comply with the requirements of this Agreement. Any person accessing this vaccine is subject to compliance with the terms of this Agreement, including any updates to the Agreement as noted in paragraph 2 below.
  
  This vaccine remains property of the United States government and subject to the terms of this Agreement until the dose is administered to the vaccine recipient.
  
  [1] The HHS Monkeypox Vaccination Program includes JYNNEOS™ and ACAM2000® vaccines.
  
  
• Subjects:
  Disease Outbreaks Mpox (monkeypox)/prevention & Control Smallpox Vaccine Vaccination
• Document Type:
  Webpage
• Name as Subject:
  ACAM2000® ; JYNNEOS® ; ACAM2000® ; JYNNEOS®
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:b2b568b73e3e58fad4793b03705dd7f0b7dcb7288ade6aa4e28c76e1b1e98906
• Download URL:
  https://stacks.cdc.gov/view/cdc/121243/cdc_121243_DS1.pdf
• File Type:
  [PDF - 446.54 KB ]